Voloridge Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.17M | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $15M | Sell |
|
|||||
|
2024
Q2 | $119M | Buy |
|
|||||
|
2024
Q1 | $147M | Sell |
|
|||||
|
2023
Q4 | $256M | Buy |
|
|||||
|
2023
Q3 | $135M | Buy |
|
|||||
|
2023
Q2 | $120M | Buy |
|
|||||
|
2023
Q1 | $8.38M | Sell |
|
|||||
|
2022
Q4 | $22.7M | Buy |
|
|||||
|
2022
Q3 | $19.1M | Sell |
|
|||||
|
2022
Q2 | $131M | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $50.1M | Buy |
|
|||||
|
2021
Q1 | $28.7M | Buy |
|
|||||
|
2020
Q4 | $16.1M | Buy |
|
|||||
|
2020
Q3 | $6.16M | Sell |
|
|||||
|
2020
Q2 | $32.1M | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $18.1M | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $35.3M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $201K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $5.76M | Sell |
|
|||||
|
2017
Q3 | $6.88M | Sell |
|
|||||
|
2017
Q2 | $21.6M | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $69.4M | Buy |
|
|||||
|
2016
Q1 | $16.2M | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $39.6M | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $1.03M | Buy |
|